Jean‐Marc Hoffmann

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

Jean‐Marc Hoffmann, Maria‐Luisa Schubert, Lei Wang et al. · Frontiers in Immunology · 2018 · 96 citations · Full text

Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients

Sophia Stock, Rudolf Übelhart, Maria‐Luisa Schubert et al. · International Journal of Cancer · 2019 · 78 citations · Full text

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Wenjie Gong, Jean‐Marc Hoffmann, Sophia Stock et al. · Cancer Immunology Immunotherapy · 2019 · 50 citations · Full text

Inflammation, Autoimmune Disease, T-regulatory Cell +10

Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation

Maria‐Luisa Schubert, Angela Hückelhoven, Jean‐Marc Hoffmann et al. · Human Gene Therapy · 2016 · 38 citations

Lymphoid Neoplasia, Cell Therapy, Transplantation +14

Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects

Lei Wang, Ming Ni, Angela Hückelhoven‐Krauss et al. · Frontiers in Immunology · 2018 · 30 citations · Full text